Oldak, L.; Chludzinska-Kasperuk, S.; Milewska, P.; Grubczak, K.; Reszec, J.; Gorodkiewicz, E.
Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy. Biomedicines 2022, 10, 2290.
https://doi.org/10.3390/biomedicines10092290
AMA Style
Oldak L, Chludzinska-Kasperuk S, Milewska P, Grubczak K, Reszec J, Gorodkiewicz E.
Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy. Biomedicines. 2022; 10(9):2290.
https://doi.org/10.3390/biomedicines10092290
Chicago/Turabian Style
Oldak, Lukasz, Sylwia Chludzinska-Kasperuk, Patrycja Milewska, Kamil Grubczak, Joanna Reszec, and Ewa Gorodkiewicz.
2022. "Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy" Biomedicines 10, no. 9: 2290.
https://doi.org/10.3390/biomedicines10092290
APA Style
Oldak, L., Chludzinska-Kasperuk, S., Milewska, P., Grubczak, K., Reszec, J., & Gorodkiewicz, E.
(2022). Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy. Biomedicines, 10(9), 2290.
https://doi.org/10.3390/biomedicines10092290